Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...
As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...
- Secures $3.2m in PIPE Financing - - $50m Term Sheet Obtained for Available Financing under Equity Line of Credit - ...
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis ...
An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...
Then there’s physical activity: Many of the symptoms of lupus, such as joint pain, fatigue, and depression, may make patients ...
UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...
Headquartered in Cambridge, the United Kingdom, Bicycle Therapeutics plc (NASDAQ:BCYC) is a clinical-stage biopharmaceutical ...
There are many reasons someone may get sick frequently, from your environment and lifestyle to genetics and underlying ...
Throughout his career, he has held key positions in private and public biotech companies, with a particular expertise in cancer and autoimmune disease drug development ... and in 2021 was recognized ...
Chip Chick on MSN4d
She's Explaining The Symptoms She Thought Were Normal, But Actually Pointed To An Autoimmune DiseaseNicky, who goes by @nickyshairandbeauty on TikTok, is on a mission to raise awareness for the symptoms she thought were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback